Trevi Therapeutics, Inc.

Invesco Ltd. TRVI
Report date
6/30/2026
Quarter
2026 Q2
Filed
8/14/2026
Shares
311,749
Value ($000)
5,814
Weight
0.0%
2023 Q2 - 2026 Q2 (13 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).